Liquid Nutritional Supplement on Malnutrition Hospitalized Patient
NCT ID: NCT04036825
Last Updated: 2019-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
138 participants
INTERVENTIONAL
2019-08-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of a High-Protein Liquid Dietary Supplementation
NCT04911712
Impact of Nutritional Status on Clinical Outcome in PICU
NCT04301791
A Need-based Nutritional Intervention in Nursing Home Residents
NCT01741870
Nutrition Supplementation in Hospitalized Patients
NCT02632630
Combining Nutrition Supplementation With an Exercise Program in Elderly Malnourished Frail Patients After Hospital Stay
NCT05325697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liquid Nutritional Supplement from Hospital Product
This group received liquid nutritional supplement from hospital product. The product is in a form of low lactose milk ready to drink with volume 200 ml and will be given 2 times daily for 14 days. This product is consist of 1.017 kcal/ml, 10 vitamin and 9 mineral
Liquid Nutritional Supplement from Hospital Product
Liquid Nutritional Supplement from Hospital Product is given 2 times daily for 14 days
Placebo
This group received standard liquid nutritional supplement as a placebo. Placebo will be given 2 times daily for 14 days
Placebo
Standard nutritional supplement is given 2 times daily as placebo for 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liquid Nutritional Supplement from Hospital Product
Liquid Nutritional Supplement from Hospital Product is given 2 times daily for 14 days
Placebo
Standard nutritional supplement is given 2 times daily as placebo for 14 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* malnutrition hospitalized patient based on European Society for Clinical Nutrition and Metabolism (ESPEN) 2015 criteria
* agreed to participate
Exclusion Criteria
* chronic kidney disease stage III-V
* decompensated hepatic cirrhosis
* allergic to milk or lactose intolerance
* could not be randomised and participate in this study by clinical judgement
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fakultas Kedokteran Universitas Indonesia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marcellus Simadibrata, Prof. PhD., SpPD, KGEH
Prof. dr. Marcellus Simadibrata, Ph.D., SpPD-KGEH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcellus Simadibrata
Role: PRINCIPAL_INVESTIGATOR
Division Of Gastroenterology Department Of Internal Medicine Faculty Of Medicine Universitas Indonesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
Jakarta Pusat, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-01-0082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.